Clinical Trial to Evaluate the Efficacy and Safety of Nexpowder™ for Diverticular Bleeding in the Lower Gastrointestinal Tract

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age19+

SponsorNext Biomedical Co., Ltd.

About this trial

Clinical Trial to Evaluate the Efficacy and Safety of Nexpowder™ for Diverticular Bleeding in the Lower Gastrointestinal Tract

Adults aged 19 years or older at the time of screening

Patients diagnosed with diverticular bleeding

Patients diagnosed with upper gastrointestinal bleeding

60 Participants

are divided into 1 treatment group

Next Biomedical Co., Ltd.

Lead sponsor